Chrisandra Shufelt, MD, on using a cardiovascular risk score to guide hormone therapy candidacy at menopause.
|Articles|June 22, 2011
Discussions for Medical Professionals
Author(s)OBGYN.net Staff
The discussion forums listed above are for medical professionals only. If you are a patient seeking to talk with other patients, please read this disclaimer, then browse the patient discussions.
Advertisement
Join the discussion with other healthcare providers
General OB/Gyn Topics
OB/Gyn Ultrasound Topics
The Early Years of Ultrasound
In Spanish
In Portuguese
Interns & Residents
Latest Technology
OB/Gyn Nursing Topics
The discussion forums listed above are for medical professionals only. If you are a patient seeking to talk with other patients, please
Advertisement
Related to this article
The October 30 update from the FDA follows the February 12, 2026 labeling changes to 6 menopausal hormone therapy products in which the agency also removed safety-related boxed warnings.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.
Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
FDA removes boxed warnings from 3 more menopausal hormone therapy products
3
Chrisandra Shufelt, MD, on cardiovascular risk assessment and menopause care
4
Chrisandra Shufelt, MD, on cardiovascular prevention at menopause
5